核药今年最大合作诞生;康诺亚配股融资8.64亿港币

氨基观察
Jun 12, 2025

核药继续受到追捧。6月10日,百时美施贵宝宣布,全资子公司RayzeBio获得Philochem AG核药OncoACP3(一种针对癌症的临床阶段治疗和诊断剂)的全球独家权利。根据协议条款,Philochem将获得3.5亿美元的预付款,以及高达10亿美元的开发、监管和商业里程碑,潜在总金额达13.5亿美元(约合人民币97亿元)。18A企业抓住再融资窗口。6月11日,康诺亚公告表示,拟以每股...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10